SCHEMBL3847124

SCHEMBL3847124

Cc1cccc(N2CCN(c3ncnc4ccc(-c5cnn(C(c6ccccc6)(c6ccccc6)C6C=CC=CC6)c5)cc34)CC2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.42
ALDH1A1 P00352 14/20 0.38
CYP1A2 P05177 10/20 0.38
CYP3A4 P08684 10/20 0.38
CLK4 Q9HAZ1 9/20 0.38
HIF1A Q16665 8/20 0.38
LMNA P02545 7/20 0.38
USP2 O75604 7/20 0.38
MEN1 O00255 6/20 0.38
KMT2A Q03164 6/20 0.38
MAPK1 P28482 6/20 0.38
TSHR P16473 5/20 0.38
CYP2D6 P10635 6/20 0.38
ALOX15 P16050 1/20 0.38
CYP2C19 P33261 7/20 0.37
SMN1; SMN2 Q16637 5/20 0.37
HPGD P15428 3/20 0.37
KDM4E B2RXH2 2/20 0.37
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846738 0.93 ACHE (0.39) MAPTALDH1A1CYP1A2CYP3A4CLK4
SCHEMBL3845846 0.91 PHGDH (0.41) ALDH1A1CYP1A2CYP3A4CLK4HIF1A
SCHEMBL3853440 0.89 CYP3A4 (0.37) ALDH1A1CYP1A2CYP3A4CLK4HIF1A
SCHEMBL4716053 0.88 CNR1 (0.38) ALDH1A1CYP1A2CYP3A4CLK4HIF1A
SCHEMBL3846797 0.86 CYP3A4 (0.49) MAPTALDH1A1CYP1A2CYP3A4CLK4
SCHEMBL3846271 0.85 CYP3A4 (0.40) MAPTALDH1A1CYP1A2CYP3A4CLK4
SCHEMBL3847121 0.84 MAPT (0.50) MAPTALDH1A1CYP1A2CYP3A4CLK4
SCHEMBL3847516 0.83 CYP3A4 (0.36) ALDH1A1CYP1A2CYP3A4CLK4HIF1A
SCHEMBL3845654 0.81 ACHE (0.38) MAPTALDH1A1CYP1A2CYP3A4CLK4
SCHEMBL3852228 0.81 CYP3A4 (0.36) ALDH1A1CYP1A2CYP3A4CLK4HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed